3D ultrasound could spot leftover skin cancer cells right after surgery
NCT ID NCT07402616
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether a 3D ultrasound scan of removed skin cancer tissue can accurately measure how deep the tumor goes. Researchers will compare ultrasound images to standard lab analysis. If it works, this technique might help surgeons know immediately if they got all the cancer out, possibly avoiding repeat surgeries. The study involves 30 adults with a common type of skin cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ex vivo 3D ultrasonography
What this could lead to
If successful, this could provide a faster, non-invasive way to check if all cancer was removed during surgery, reducing the need for second operations.
What could go wrong
This is a small, early feasibility study with only 30 participants. The ultrasound method may not match the accuracy of standard pathology, and results may not apply to all skin cancer types or locations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact